Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers !
Shipping Price Reduction for EU Regions
Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
---|---|---|---|---|---|
SEP-H5255 | Human | Human P-Selectin / CD62P Protein, Fc Tag | ![]() |
![]() ![]() |
|
SEP-H52E4 | Human | Human P-Selectin / CD62P Protein, His Tag | ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Crizanlizumab | Sel-G-1; SEG-101; Sel-G1 | Approved | Selexys Pharmaceuticals Corp | Adakveo | United States | Anemia, Sickle Cell | Novartis Pharmaceuticals Corp | 2019-11-15 | Coronavirus Disease 2019 (COVID-19); Leukoencephalopathies; Priapism; Primary Myelofibrosis; Anemia, Sickle Cell | Details |
Crizanlizumab | Sel-G-1; SEG-101; Sel-G1 | Approved | Selexys Pharmaceuticals Corp | Adakveo | United States | Anemia, Sickle Cell | Novartis Pharmaceuticals Corp | 2019-11-15 | Coronavirus Disease 2019 (COVID-19); Leukoencephalopathies; Priapism; Primary Myelofibrosis; Anemia, Sickle Cell | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Inclacumab | RG-1512; RO-4905417; LC-1004-002; DSM-ACC-2641; R-1512 | Phase 3 Clinical | F. Hoffmann-La Roche Ltd, Genmab A/S | Pain; Myocardial Infarction; Graft Occlusion, Vascular; Anemia, Sickle Cell; Peripheral Arterial Disease | Details |
Rivipansel Sodium | PF-6460031; PF-06460031-02; PF-06460031 (free base); GM-1070; GMI-1070 | Phase 3 Clinical | Glycomimetics Inc | Pain; Kidney Diseases; Anemia, Sickle Cell | Details |
Dociparstat sodium | ODSH; CX-01; PGX-100; PGX-ODSH-2013-AML-1 | Phase 1 Clinical | Paringenix | Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Myelodysplastic Syndromes; Protein-Losing Enteropathies; Pulmonary Disease, Chronic Obstructive; Leukemia, Myeloid, Acute; Acute Lung Injury | Details |
Inclacumab | RG-1512; RO-4905417; LC-1004-002; DSM-ACC-2641; R-1512 | Phase 3 Clinical | F. Hoffmann-La Roche Ltd, Genmab A/S | Pain; Myocardial Infarction; Graft Occlusion, Vascular; Anemia, Sickle Cell; Peripheral Arterial Disease | Details |
Rivipansel Sodium | PF-6460031; PF-06460031-02; PF-06460031 (free base); GM-1070; GMI-1070 | Phase 3 Clinical | Glycomimetics Inc | Pain; Kidney Diseases; Anemia, Sickle Cell | Details |
Dociparstat sodium | ODSH; CX-01; PGX-100; PGX-ODSH-2013-AML-1 | Phase 1 Clinical | Paringenix | Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Myelodysplastic Syndromes; Protein-Losing Enteropathies; Pulmonary Disease, Chronic Obstructive; Leukemia, Myeloid, Acute; Acute Lung Injury | Details |
This web search service is supported by Google Inc.